At a glance
ClinicalIndex Comparison RecordN/ACompleted· 16 enrolled
Drug / intervention
THOR Laser System for Low Level Laser Therapy (LLLT)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Utilization of Low Level Laser Therapy for Radiation Induced Dermatitis in Patients With Head and Neck Squamous Cell Carcinoma
In Brief
A clinical study evaluating THOR Laser System for Low Level Laser Therapy (LLLT) for Radiation Dermatitis. Completed, enrolled 16 participants across 1 site.
Detailed Summary
This study will assess the efficacy of LLLT to mitigate and ameliorate the acneiform-rash, radiation dermatitis, and pain, while assessing its impact on patient reported quality of life.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRadiation Dermatitis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 2015
Enrollment StartApr 2015
Primary CompletionOct 2020
TodayJul 2026
First PostedMar 10, 2015
Enrollment StartApr 27, 2015
Primary CompletionOct 13, 2020
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 11.3 years ago
Interventions
THOR Laser System for Low Level Laser Therapy (LLLT)device
Non-invasive, a cold laser output treatment.